Nefopam by continuous intravenous injection and adverse drug reactions: which causality assessment?;Néfopam en perfusion continue et effets secondaires indésirables : quelle imputabilité ?

Annales Francaises d'Anesthesie et de Reanimation

Volumn 26, Issue 1, 2007, Pages 74-76

  Ould Ahmed, M ^a   Drouillard, I ^a   El Kartouti, A ^a   Wey, P F ^a   Lions, C ^a   Martinez, J Y ^a  

^a HIA Desgenettes   (France)

Author keywords

Adverse drug reactions; Causality assessment; Nefopam

Indexed keywords

AMLODIPINE; EPHEDRINE; HETASTARCH; HYPERHES; MORPHINE; NEFOPAM; PARACETAMOL; PROPOFOL; REMIFENTANIL; ROPIVACAINE; UNCLASSIFIED DRUG; ANALGESIC AGENT;

ACUTE KIDNEY FAILURE; AGED; ANEMIA; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; CREATININE CLEARANCE; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; HYPOPROTEINEMIA; INTRAVENOUS ANESTHESIA; LAPAROTOMY; LUMBAR PUNCTURE; MALE; NEUROLOGIC DISEASE; POSTOPERATIVE ANALGESIA; RADIODENSITOMETRY; SPLENECTOMY; UNSPECIFIED SIDE EFFECT; CHEMICALLY INDUCED DISORDER; INTRAVENOUS DRUG ADMINISTRATION; POSTOPERATIVE PAIN;

AGED; ANALGESICS, NON-NARCOTIC; HUMANS; HYPOPROTEINEMIA; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; MALE; NEFOPAM; PAIN, POSTOPERATIVE;

EID: 33846061092     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2006.07.080     Document Type: Article

References (11)

1. Hell R.C., Brogden R.N., Pakes G.E., Speight T.M., and Avery G.S. Nefopam: a review of its pharmacological properties and therapeutic efficacy. Drugs 19 (1980) 249-267
2. Chawla J., Le Guern M.E., Alquier C., Kalhorn T.F., and Levy R.H. Effect of route of administration on the pharmacokinetic behavior of enantiomers of nefopam and desmethylnefopam. Ther. Drug Monit. 25 (2003) 203-210
3. Alfonsi P., Adam F., Passard A., Guignard B., Sessler D.I., and Chauvin M. Nefopam, a nonsedative benzoxazocine analgesic, selectively reduces the shivering threshold in unanesthetized subjects. Anesthesiology 100 (2004) 37-43
4. Piercy D.M., Cumming J.A., Dawling S., and Henry J.A. Death due to overdose of nefopam. BMJ 283 (1981) 1508-1509
5. Urwin S.C., and Smith H.S. Fatal nefopam overdose. Br. J. Anaesth. 83 (1999) 501-502
6. Godier A., Babinet A., El Metaoua S., Fulgencio J.P., and Bonnet F. Une nouvelle cause de syndrome confusionnel postopératoire : la prise de néfopam. Ann. Fr. Anesth. Reanim. 21 (2002) 538-539
7. Aymard G., Warot D., Demolis P., Giudicelli J.F., Lechat P., Le Guern M.E., et al. Comparative pharmacokinetics and pharmacodynamics of intravenous and oral nefopam in healthy volunteers. Pharmacol. Toxicol. 92 (2003) 279-286
8. Mather G.G., Labroo R., Le Guern M.E., Lepage F., Gillardin J.M., and Levy R.H. Nefopam enantiomers: preclinical pharmacoly/toxicology and pharmacokinetic characteristics in healthy subjects after intravenous administration. Chirality 12 (2000) 153-159
9. Bégaud B., Evreux J.C., Jouglard J., and Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments : actualisation de la méthode utilisée en France. Therapie 40 (1985) 111-118
10. Pillans P.I., and Woods D.J. Adverse reactions associated with nefopam. N. Z. Med. J. 108 (1995) 832-834
11. Tramoni G., Viale J.P., Cazals C., and Bhageerutty K. Morphine-sparing effect of nefopam by continuous intravenous injection after surgery by laparotomy. Eur. J. Anaesthesiol. 20 (2003) 990-992